Commercial terms and exact-model provenance remain subject to current source checks.
Reader service card
Practice ownership and buying signals
OwnershipNo reader benchmark yet
EvaluationNo reader benchmark yet
Replacement intentNo reader benchmark yet
SponsorNo sponsor
Device Pulse is not collecting these actions on this page. Disabled controls show the planned reader service without creating a response, lead, sponsor relationship, or vendor request.
Activation requires a separate consent notice, controlled storage, duplicate and suppression rules, retention and deletion controls, named vendor-transfer disclosure, and an audit log. Newsletter signup does not activate these controls.
Overview
MOXI is a Sciton platform in the skin resurfacing category. The manufacturer describes it as using 1927 nm fractionated non-ablative diode laser with rolling single-use tip for face, neck, chest, hands, arms, legs. Those specifications are company-reported, not an independent performance conclusion.
Sciton reports a 1927 nm wavelength, 100-200 micrometer depth range, and 8-10 minute procedure time. Those specifications are company-reported. The cited FDA records establish only the device names, classifications, or indications stated in those records. They do not establish comparative superiority, outcomes for every patient, or current commercial terms.
Before purchase, request the exact model, cleared indications, software version, handpieces, service coverage, training, and a written quote. Pricing and operating economics remain unknown where a current source packet was not available.
TREATMENT AREAS
Face, Neck, Chest, Hands, Arms, Legs
TREATMENT TIME
Sciton reports 8-10 minutes, excluding numbing time
SESSIONS
Sciton describes 2-4 treatments depending on treatment level and goals
PER SESSION
Practice-set; no verified range
CONSUMABLES/YR
Single-use tip economics require a current quote
MAINTENANCE/YR
Service quote required
Pros & Cons
Pros
The manufacturer publishes wavelength, depth, power, and timing specifications
Three treatment levels support different density and energy settings
The rolling tip tracks treatment duration
The system targets lower-intensity resurfacing workflows with limited downtime
Cons
The exact current FDA clearance path has not been reconciled in this profile
Single-use tip and acquisition pricing are not public
The broader mJOULE adverse-event record includes burn and blister reports
Company claims about suitability across skin types require protocol-specific clinical judgment
Clinical Evidence
The manufacturer publishes technical specifications and treatment guidance. An independent study table and model-specific regulatory crosswalk remain incomplete.
This profile does not treat a clearance record or manufacturer page as proof of superior outcomes. Match each clinical claim to the exact model, indication, study design, sample size, source date, and funding disclosure.
The current packet supports product identification and the limited regulatory statements shown here. Independent comparative effectiveness, local demand, and practice economics remain open diligence questions.
ROI Analysis
Device Pulse is not publishing a payback estimate for MOXI because current transaction price, financing, service, consumables, staffing, and local patient demand have not been independently verified.
Build the decision from your written quote. Model conservative monthly treatment volume, realized revenue per treatment, consumables, operator time, service, downtime, financing, and patient-acquisition cost. Run a downside case before using the model in a purchase decision.
A manufacturer projection is an input to test, not a forecast. Ask for every assumption in writing and compare it with your scheduling capacity and historical conversion data.
Best For
Dermatology and aesthetic practices comparing a lower-intensity 1927 nm resurfacing workflow and willing to verify tip costs, current labeling, training, and conservative patient demand.
Use that as a short-list hypothesis. Confirm the exact indication, patient mix, operator training, local service, workflow, and written commercial terms before deciding that the platform fits the practice.
Buying Guide
Request a written, model-specific quote for MOXI. Separate the console, handpieces, software, training, installation, warranty, service, and recurring supplies or licensing.
Confirm the serial number, current software, cleared indications, ownership-transfer terms, parts availability, response time, and local service provider. Do not assume a product-page feature applies to every configuration.
Ask Sciton to identify which statements are specifications, which are company-reported claims, and which are supported by independent clinical evidence. Keep those records with the final contract.
Alternatives to review
Use these profiles to build a short list. An alternative listing is not a claim of equivalence or superiority.
Clear + Brilliant Touch: Dermatology and aesthetic practices comparing a lower-intensity fractional resurfacing option and willing to verify treatment-credit economics and exact handpie
NEW Manufacturer quote required · USED No reconciled dated sample
LaseMD Ultra: Med spas and dermatology practices that want a low-downtime resurfacing option at a reasonable capital cost. Practices that can package ampoule add-ons into per
Fraxel Dual: Dermatology practices that treat melasma and photodamaged skin on mixed patient populations. Practices that value brand recognition and a deep evidence base.
Halo: High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Jou
NEW $145,000-$210,000 (as Joule module) · USED $80,000-$140,000
A current acquisition price was not published in the reviewed source packet. Request a written quote from Sciton that separates the console, handpieces, software, training, installation, warranty, service, and recurring supplies.
What is the FDA status of MOXI?
Sciton markets MOXI as a 1927 nm fractionated non-ablative laser on mJOULE. Device Pulse has not yet reconciled the exact current MOXI configuration to a model-specific FDA summary.
What evidence supports this MOXI profile?
The manufacturer publishes technical specifications and treatment guidance. An independent study table and model-specific regulatory crosswalk remain incomplete. The source packet separates FDA public records from manufacturer-reported product information. It does not establish comparative superiority.
Which practices should evaluate MOXI?
Dermatology and aesthetic practices comparing a lower-intensity 1927 nm resurfacing workflow and willing to verify tip costs, current labeling, training, and conservative patient demand. That is an editorial fit question, not a clinical or financial conclusion.
What should a buyer verify before ordering MOXI?
Verify the exact model, cleared indications, handpieces, software, serial-number history, training, service response, warranty, ownership-transfer terms, recurring supplies, and every commercial assumption in writing.
What are the main limitations in this MOXI profile?
Current limitations include: The exact current FDA clearance path has not been reconciled in this profile; Single-use tip and acquisition pricing are not public; The broader mJOULE adverse-event record includes burn and blister reports. Recheck the dated primary sources before using the profile in a purchase decision.
Get the Device Quote Review Kit
Open the printable buyer checklist now, then get the planned Tuesday brief with price, FDA, safety, evidence, and manufacturer signals.
Free kit available immediately. Planned Tuesday brief. Unsubscribe anytime. Privacy.
